Live Breaking News & Updates on Praxis Precision Medicines

Stay updated with breaking news from Praxis precision medicines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Robert W. Baird

Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Robert W. Baird
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Connor-clark-lunn-investment-management-ltd , Praxis-precision-medicines-inc , Jefferies-financial-group , Simplex-trading , York-mellon-corp , Citigroup-inc , Jump-financial , Praxis-precision-medicines , Free-report , Financial-group

Short Interest in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Expands By 77.1%

Short Interest in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Expands By 77.1%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Windmill-hill-asset-management-ltd , Nasdaq , Jefferies-financial-group , Wealth-advisors , Victory-capital-management-inc , Simplex-trading , Praxis-precision-medicines-inc , Praxis-precision-medicines , Get-free-report , Capital-management , Hill-asset-management-ltd

HC Wainwright Reiterates "Buy" Rating for Praxis Precision Medicines (NASDAQ:PRAX)

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Friday, Benzinga reports. They presently have a $105.00 price objective on the stock. HC Wainwright’s target price indicates a potential upside of 91.61% from the company’s previous close. PRAX […] ....

Connor-clark-lunn-investment-management-ltd , Nasdaq , Praxis-precision-medicines-inc , Asset-management-inc , Jefferies-financial-group , Silverarc-capital-management , Jump-financial , York-mellon-corp , Praxis-precision-medicines , Get-free-report , Financial-group

Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $105.00 price objective on the stock. Other analysts have also issued reports about the company. Wedbush boosted their price objective on Praxis Precision […] ....

Acuta-capital-partners , Praxis-precision-medicines-inc , Citigroup-inc , Silverarc-capital-management , Jefferies-financial-group , Asset-management-inc , Praxis-precision-medicines , Free-report , Financial-group , Precision-medicines , Get-free-report